SCHEMBL6657441

SCHEMBL6657441

N#Cc1ccccc1Oc1cccc(C=O)c1OCC(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
GAA P10253 3/20 0.36
POLB P06746 1/20 0.36
AR P10275 4/20 0.36
SLC22A12 Q96S37 1/20 0.34
BCAT2 O15382 1/20 0.34
BCAT1 P54687 1/20 0.34
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
RAB9A P51151 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
SCN9A Q15858 1/20 0.33
MAP4K4 O95819 1/20 0.33
MAPK1 P28482 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5349933 0.87 AR (0.39) ARSLC22A12BCAT2BCAT1
SCHEMBL4911171 0.75 HTR1A (0.46) SMN1; SMN2ALDH1A1HPGDGAAPOLB
SCHEMBL29530991 0.75 HTR1A (0.46) SMN1; SMN2ALDH1A1HPGDGAAPOLB
SCHEMBL4739057 0.74 AR (0.40) ALDH1A1ARKDM4EKMT2A
SCHEMBL5344230 0.73 AR (0.45) ARBCAT2BCAT1
SCHEMBL1804090 0.72 ALDH1A1 (0.66) SMN1; SMN2ALDH1A1HPGDHTTGAA
SCHEMBL5341131 0.71 SLC22A12 (0.39) SMN1; SMN2ALDH1A1HPGDHTTSLC22A12
SCHEMBL3581845 0.71 CA1 (0.49) SMN1; SMN2ALDH1A1HPGDHTTKDM4E
SCHEMBL5346988 0.71 SLC22A12 (0.41) SMN1; SMN2ARSLC22A12KDM4ELMNA
SCHEMBL14835744 0.70 PIM1 (0.43) SMN1; SMN2ALDH1A1HPGDHTTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1434756-A1 NOVEL COMPOUNDS AstraZeneca AB (SE) 2004-07-07 EP disclosed
WO-2003029185-A1 NOVEL COMPOUNDS ASTRAZENECA AB (SE) 2003-04-10 WO disclosed